Age-Specific Seasonal Influenza Vaccine Effectiveness against Different Influenza Subtypes in the Hospitalized Population in Lithuania during the 2015-2019 Influenza Seasons.
Monika KulieseAukse MickieneLigita JancorieneBirute ZablockieneGiedre Gefenaitenull Study GroupPublished in: Vaccines (2021)
Point estimates suggest high SIVE against influenza A in 18-64-year-old participants, and against influenza B and B/Yamagata in those 65 years old and older.